K. Baba

Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate.

M. Kinoshita, K. Minakuchi, H. Houchi, 2002, Journal of pharmaceutical sciences.

Antiangiogenic cancer therapy using tumor vasculature-targeted liposomes encapsulating 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one, SU5416.

N. Oku, T. Asai, K. Shimizu, 2008, Cancer letters.

Potential usage of liposomal 4beta-aminoalkyl-4'-O-demethyl-4-desoxypodophyllotoxin (TOP-53) for cancer chemotherapy.

Kosuke Shimizu, Miki Takada, Tomohiro Asai, 2002, Biological & pharmaceutical bulletin.

Pharmaceutical evaluation of hollow type suppositories. IV. Improvement of bioavailability of propranolol in rabbits after rectal administration.

K. Baba, Y. Matsumoto, M. Matsumoto, 1986, Journal of pharmacobio-dynamics.

Anti‐neovascular therapy by liposomal drug targeted to membrane type‐1 matrix metalloproteinase

H. Tsukada, N. Oku, T. Asai, 2004, International journal of cancer.

Highly Stabilized Amorphous 3-bis(4-Methoxyphenyl)methylene-2-indolinone (TAS-301) in Melt-Adsorbed Products with Silicate Compounds

M. Kinoshita, K. Minakuchi, H. Houchi, 2003, Drug development and industrial pharmacy.